Identification of TDP-43 as an oncogene in melanoma and its function during melanoma pathogenesis

References

• Olszanski AJ. Current and future roles of targeted therapy and immunotherapy in advanced melanoma. J Manag Care Spec Pharm 2014; 20:346-56; PMID:24684639; http://dx.doi.org/10.18553/jmcp.2014.20.4.346
   PubMed Web of Science ®Google Scholar
• Zhou J, Xu D, Xie H, Tang J, Liu R, Li J, Wang S, Chen X, Su J, Zhou X, et al. miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1alpha. Cancer Biol Ther 2015; 16:846-55; PMID:25891797; http://dx.doi.org/10.1080/15384047.2015.1030545
   PubMed Web of Science ®Google Scholar
• Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27:6199-206; PMID:19917835; http://dx.doi.org/10.1200/JCO.2009.23.4799
   PubMed Web of Science ®Google Scholar
• Rigel DS, Russak J, Friedman R. The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin 2010; 60:301-16; PMID:20671054; http://dx.doi.org/10.1017/S0009840X09991491
   PubMed Web of Science ®Google Scholar
• Cohen TJ, Lee VM, Trojanowski JQ. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med 2011; 17:659-67; PMID:21783422; http://dx.doi.org/10.1016/j.molmed.2011.06.004
   PubMed Web of Science ®Google Scholar
• Park YY, Kim SB, Han HD, Sohn BH, Kim JH, Liang J, Lu Y, Rodriguez-Aguayo C, Lopez-Berestein G, Mills GB, et al. Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520. Hepatol (Baltimore, Md) 2013; 58:182-91; PMID:23389994; http://dx.doi.org/10.1002/hep.26310
   PubMed Web of Science ®Google Scholar
• Stallings NR, Puttaparthi K, Dowling KJ, Luther CM, Burns DK, Davis K, Elliott JL. TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis. PloS One 2013; 8:e71793; PMID:23967244; http://dx.doi.org/10.1371/journal.pone.0071793
   PubMed Web of Science ®Google Scholar
• Warraich ST, Yang S, Nicholson GA, Blair IP. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases. Int J Biochem Cell Biol 2010; 42:1606-9; PMID:20601083; http://dx.doi.org/10.1016/j.biocel.2010.06.016
   PubMed Web of Science ®Google Scholar
• Postel-Vinay S, Veron AS, Tirode F, Pierron G, Reynaud S, Kovar H, Oberlin O, Lapouble E, Ballet S, Lucchesi C, et al. Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nat Genet 2012; 44:323-7; PMID:22327514; http://dx.doi.org/10.1038/ng.1085
   PubMed Web of Science ®Google Scholar
• Guo F, Jiao F, Song Z, Li S, Liu B, Yang H, Zhou Q, Li Z. Regulation of MALAT1 expression by TDP43 controls the migration and invasion of non-small cell lung cancer cells in vitro. Biochem Biophys Res Commun 2015; 465:293-8; PMID:26265046; http://dx.doi.org/10.1016/j.bbrc.2015.08.027
   PubMed Web of Science ®Google Scholar
• Slominski A, Kim TK, Brozyna AA, Janjetovic Z, Brooks DL, Schwab LP, Skobowiat C, Jozwicki W, Seagroves TN. The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1alpha expression and HIF-dependent attendant pathways. Arch Biochem Biophys 2014; 563:79-93; PMID:24997364; http://dx.doi.org/10.1016/j.abb.2014.06.030
   PubMed Web of Science ®Google Scholar
• Liao H, Wang Z, Deng Z, Ren H, Li X. Curcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1-MMP/MMP2 pathway. Int J Clin Exp Med 2015; 8:8948-57; PMID:26309547
   PubMed Web of Science ®Google Scholar
• Garrido P, Osorio FG, Moran J, Cabello E, Alonso A, Freije JM, Gonzalez C. Loss of GLUT4 induces metabolic reprogramming and impairs viability of breast cancer cells. J Cell Physiol 2015; 230:191-8; PMID:24931902; http://dx.doi.org/10.1002/jcp.24698
   PubMed Web of Science ®Google Scholar
• Dey P, Rachagani S, Chakraborty S, Singh PK, Zhao X, Gurumurthy CB, Anderson JM, Lele S, Hollingsworth MA, Band V, et al. Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. Clin Cancer Res 2012; 18:6188-98; PMID:22977192; http://dx.doi.org/10.1158/1078-0432.CCR-12-1789
   PubMed Web of Science ®Google Scholar
• Mishra RK, Wei C, Hresko RC, Bajpai R, Heitmeier M, Matulis SM, Nooka AK, Rosen ST, Hruz PW, Schiltz GE, et al. In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy. J Biol Chem 2015; 290:14441-53; PMID:25847249; http://dx.doi.org/10.1074/jbc.M114.628826
   PubMed Web of Science ®Google Scholar
• Biswas G, Guha M, Avadhani NG. Mitochondria-to-nucleus stress signaling in mammalian cells: nature of nuclear gene targets, transcription regulation, and induced resistance to apoptosis. Gene 2005; 354:132-9; PMID:15978749; http://dx.doi.org/10.1016/j.gene.2005.03.028
   PubMed Web of Science ®Google Scholar
• Lukavsky PJ, Daujotyte D, Tollervey JR, Ule J, Stuani C, Buratti E, Baralle FE, Damberger FF, Allain FH. Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat Struct Mol Biol 2013; 20:1443-9; PMID:24240615; http://dx.doi.org/10.1038/nsmb.2698
   PubMed Web of Science ®Google Scholar
• Liu R, Xie H, Luo C, Chen Z, Zhou X, Xia K, Chen X, Zhou M, Cao P, Cao K, et al. Identification of FLOT2 as a novel target for microRNA-34a in melanoma. J Cancer Res Clin Oncol 2015; 141:993-1006; PMID:25403318; http://dx.doi.org/10.1007/s00432-014-1874-1
   PubMed Web of Science ®Google Scholar
• Li Q, Li J, Wen T, Zeng W, Peng C, Yan S, Tan J, Yang K, Liu S, Guo A, et al. Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway. Oncotarget 2014; 5:6387-403; PMID:25051367; http://dx.doi.org/10.18632/oncotarget.2201
   PubMed Web of Science ®Google Scholar